PL4389116T3 - Farmaceutyczna wodna zawiesina flubendazolu - Google Patents
Farmaceutyczna wodna zawiesina flubendazoluInfo
- Publication number
- PL4389116T3 PL4389116T3 PL23151010.8T PL23151010T PL4389116T3 PL 4389116 T3 PL4389116 T3 PL 4389116T3 PL 23151010 T PL23151010 T PL 23151010T PL 4389116 T3 PL4389116 T3 PL 4389116T3
- Authority
- PL
- Poland
- Prior art keywords
- flubendazole
- aqueous suspension
- pharmaceutical aqueous
- pharmaceutical
- suspension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22216470 | 2022-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4389116T3 true PL4389116T3 (pl) | 2026-03-02 |
Family
ID=84604275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL23151010.8T PL4389116T3 (pl) | 2022-12-23 | 2023-01-10 | Farmaceutyczna wodna zawiesina flubendazolu |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4389116B1 (pl) |
| DK (1) | DK4389116T3 (pl) |
| ES (1) | ES3046384T3 (pl) |
| FI (1) | FI4389116T3 (pl) |
| HR (1) | HRP20251177T1 (pl) |
| LT (1) | LT4389116T (pl) |
| PL (1) | PL4389116T3 (pl) |
| PT (1) | PT4389116T (pl) |
| RS (1) | RS67263B1 (pl) |
| SI (1) | SI4389116T1 (pl) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2037914T3 (pl) | 2006-06-14 | 2014-04-30 | Intervet Int Bv | Zawiesina zawierająca karbaminian benzoimidazolu i polisorbat |
| TWI580442B (zh) * | 2011-10-19 | 2017-05-01 | 傑特大學 | 醫藥毫微懸浮物 |
-
2023
- 2023-01-10 PL PL23151010.8T patent/PL4389116T3/pl unknown
- 2023-01-10 HR HRP20251177TT patent/HRP20251177T1/hr unknown
- 2023-01-10 PT PT231510108T patent/PT4389116T/pt unknown
- 2023-01-10 EP EP23151010.8A patent/EP4389116B1/en active Active
- 2023-01-10 SI SI202330048T patent/SI4389116T1/sl unknown
- 2023-01-10 LT LTEP23151010.8T patent/LT4389116T/lt unknown
- 2023-01-10 ES ES23151010T patent/ES3046384T3/es active Active
- 2023-01-10 FI FIEP23151010.8T patent/FI4389116T3/fi active
- 2023-01-10 RS RS20250949A patent/RS67263B1/sr unknown
- 2023-01-10 DK DK23151010.8T patent/DK4389116T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| DK4389116T3 (da) | 2025-10-13 |
| SI4389116T1 (sl) | 2025-12-31 |
| ES3046384T3 (en) | 2025-12-01 |
| PT4389116T (pt) | 2025-10-06 |
| RS67263B1 (sr) | 2025-10-31 |
| HRP20251177T1 (hr) | 2025-11-21 |
| FI4389116T3 (fi) | 2025-10-16 |
| EP4389116A1 (en) | 2024-06-26 |
| LT4389116T (lt) | 2025-10-27 |
| EP4389116B1 (en) | 2025-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3994304T3 (pl) | Sposób wytwarzania produktu celulozowego i produkt celulozowy | |
| LT3993807T (lt) | Vaistą apimančios vandeninės kompozicijos ph stabilizavimo būdas | |
| EP3906019C0 (en) | Pharmaceutical compositions of furosemide | |
| EP4244818A4 (en) | Disambiguation of poses | |
| EP3930877C0 (en) | PRODUCTION OF CONCENTRATED USED DIALYSATE | |
| EP3799594A4 (en) | PRODUCTION OF OLIGOSACCHARIDS | |
| EP4003323A4 (en) | STABILIZED FORMULATIONS OF 4-AMINO-3-SUBSTITUTED BUTANOIC ACID DERIVATIVES | |
| EP3608670A4 (en) | HYDROPHILE COLORING CELLULOSE MICROPARTICLES | |
| EP4263939C0 (en) | AQUEOUS DISPERSION OF ETHYLCELLULOSE | |
| HUE065395T2 (hu) | Mikromûanyagok elválasztása | |
| PL3917749T3 (pl) | Sposób wytwarzania mieszanek skrobi | |
| IL285765A (en) | Therapeutic uses of dulaglutide | |
| PL4389116T3 (pl) | Farmaceutyczna wodna zawiesina flubendazolu | |
| IL311473A (en) | Ophthalmic pharmaceutical compositions of roflumilast | |
| IL305851A (en) | Preparation of 2-chloro-4-fluoro-5-nitrobenzoic acid | |
| EP4275007C0 (en) | DRYING OF PHARMACEUTICAL POWDERS | |
| EP4178717A4 (en) | CONTINUOUS PRODUCTION OF NANOFORESTS | |
| IL312073A (en) | Pharmaceutical compositions of efruxifermin | |
| IL313407A (en) | Enzymatic decarbamoylation of glufosinate derivatives | |
| IL313212A (en) | Solid state forms of tavapadon and processes for preparation thereof | |
| EP4228584C0 (en) | Medication delivery | |
| EP4192440C0 (en) | TTS COMPRISING ESKETAMINE SUSPENSION | |
| EP3760205A4 (en) | AQUATIC SUSPENSION TYPE PHARMACEUTICAL PREPARATION | |
| PL4231859T3 (pl) | Sposób kontroli pałeczkowato ukształtowanych wyrobów | |
| EP3500590A4 (en) | PRODUCTION AND USE OF PHOSPHOETHANOLAMINE CELLULOSE AND DERIVATIVES |